[FATE] QoQ Quarter Result on 31-Dec-2012 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
30-Dec-2012
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -1.02%
YoY-
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 0 -971 209 290 472 643 528 -
PBT -6,980 -5,739 -6,073 -5,534 -3,548 -4,155 -4,113 42.32%
Tax 0 -1,633 0 88 100 291 0 -
NP -6,980 -5,739 -6,073 -5,534 -3,548 -4,155 -4,113 42.32%
Tax Rate - - - - - - - -
Total Cost 6,980 4,768 6,282 5,824 4,020 4,798 4,641 31.30%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin 0.00 591.04 -2,905.74 -1,908.28 -751.69 -646.19 -778.98 -
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -0.34 -0.29 -0.32 -0.29 -0.40 -0.47 -0.46 -18.26%
EPS Diluted -0.34 -0.28 -0.32 -0.29 -0.40 -0.47 -0.46 -18.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.